To further bolster the clinical relevance of this model, we crossed SNF5 and p53 floxed mice, as p53 deletions are highly recurrent in the most aggressive and chemorefractory PTCL (26). This evidence concerns the gene TP53 and mature T-cell and NK-cell non-Hodgkin lymphoma.